Orchid BioSciences Europe Limited 22 Blacklands Way Abingdon Business Park Abingdon Oxfordshire OX14 1DY Tepnel Diagnostics Limited Heron House Oaks Business Park Crewe Road Wythenshawe Manchester M23 9HZ Orchid BioSciences, Inc 4390 U.S. Route 1...Sale Agreement • February 5th, 2004 • Orchid Biosciences Inc • In vitro & in vivo diagnostic substances
We refer to the Agreement dated 30 October 2003 between Orchid Biosciences Europe Limited (the “Seller”), Tepnel Diagnostics Limited (the “Purchaser”), Orchid Biosciences, Inc and Tepnel Life Sciences plc under which the Purchaser agreed to purchase and the Seller agreed to sell the goodwill and assets comprised in the Diagnostics Business as set out in the agreement (the “Agreement”).
Orchid BioSciences Europe Limited 22 Blacklands Way Abingdon Business Park Abingdon Oxfordshire OX14 1DY Tepnel Diagnostics Limited Heron House Oaks Business Park Crewe Road Wythenshawe Manchester M23 9HZ Orchid BioSciences, Inc 4390 US Route One...Sale of Diagnostics Business • February 5th, 2004 • Orchid Biosciences Inc • In vitro & in vivo diagnostic substances
AMENDMENT, WAIVER AND REVOCATION OF TERMINATION OF ASSET PURCHASE AGREEMENTAsset Purchase Agreement • February 5th, 2004 • Orchid Biosciences Inc • In vitro & in vivo diagnostic substances
This Amendment, Waiver and Revocation of Termination of Asset Purchase Agreement (this “Amendment”) is made effective as of January 21, 2004 (the “Amendment Effective Date”) by and among Orchid BioSciences, Inc., a Delaware corporation, having its principal office at 4390 U.S. Route 1 North, Princeton, NJ 08540 (“Orchid”), Lifecodes Corporation, a Delaware corporation and wholly owned subsidiary of Orchid (“Lifecodes,” together with Orchid, the “Sellers”) and Tepnel Life Sciences plc, a company organized under the laws of the United Kingdom, having its principal office at Heron House, Oaks Business Park, Crewe Road, Wythenshawe, Manchester M23 9HZ (“Tepnel”), Tepnel North America Corporation, a Delaware corporation and wholly owned subsidiary of Tepnel (“Tepnel North America”) and Tepnel Lifecodes Corporation, a Delaware corporation and wholly owned subsidiary of Tepnel North America (“Tepnel Lifecodes,” together with Tepnel and Tepnel North America, the “Buyers”). Each of the Sellers
